Grown Rogue International (GRUSF) Net Income towards Common Stockholders Growth (1y) (2010 - 2025)
Grown Rogue International (GRUSF) Net Income towards Common Stockholders Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -388.62% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -14.93% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 460,970,719.11% |
| Jun 30, 2025 | 123.49% |
| Jan 31, 2023 | 320.41% |
| Jan 31, 2022 | 60.73% |
| Jul 31, 2021 | 93.17% |
| Apr 30, 2021 | 11.13% |
| Jan 31, 2021 | 33.08% |
| Oct 31, 2020 | 101.26% |
| Jul 31, 2020 | -4.24% |
| Apr 30, 2020 | 21.79% |
| Jan 31, 2020 | 66.47% |
| Oct 31, 2019 | 16.90% |
| Jul 31, 2019 | 47.57% |
| Apr 30, 2019 | -180.80% |
| Jan 31, 2019 | -634.88% |
| May 31, 2018 | 178,137,072.15% |
| Feb 28, 2018 | -582,809,110.13% |
| Nov 30, 2017 | 585,693,600.39% |
| May 31, 2017 | -429.42% |
| Feb 28, 2017 | 220.62% |